Navigation Links
Proof that antidepressants and breastfeeding can mix
Date:4/10/2014

University of Adelaide researchers have found that women on antidepressant medication are more successful at breastfeeding their babies if they keep taking the medication, compared with women who quit antidepressants because of concerns about their babies' health.

These results have been presented this week at the 18th Perinatal Society of Australia and New Zealand (PSANZ) Annual Conference in Perth.

Using data from the Danish National Birth Cohort in Denmark, researchers in the University of Adelaide's Robinson Research Institute studied the outcomes of 368 women who were on antidepressants prior to becoming pregnant.

"We found that two thirds of the women (67%) stopped taking their antidepressant medication either after becoming pregnant or during breastfeeding," says NHMRC Early Career Fellow Dr Luke Grzeskowiak from the Robinson Research Institute.

"A third of the women (33%) continued to take antidepressant medication throughout their pregnancy and while breastfeeding, and these women were much more successful at maintaining breastfeeding up to and beyond the recommended six months.

"In contrast, those women who had stopped taking antidepressants were also more likely to stop breastfeeding within the recommended six months."

Dr Grzeskowiak says the health benefits of continued breastfeeding greatly outweigh any perceived risk to the baby from antidepressant medication.

"This is a really important message because we know that breastfeeding has immense benefits for the child and the mum herself, including a degree of protection against post-natal depression," he says.

"The amount of antidepressant medication that finds its way into a mother's breast milk is very low. On the balance of it, we believe that continuing to take antidepressant medication and maintaining regular breastfeeding will be the best outcome for both the baby and the mother."

Dr Grzeskowiak says many women struggle with decisions about what to do with medications both during pregnancy and lactation.

"If they're taking antidepressants, they should be supported and encouraged by family members, friends and healthcare professionals to continue with their medication, knowing that good breastfeeding outcomes are all-important for them and their child," he says.


'/>"/>

Contact: Dr. Luke Grzeskowiak
luke.grzeskowiak@adelaide.edu.au
University of Adelaide
Source:Eurekalert

Related biology news :

1. Another scientific proof of the difference in social perception between men and women
2. A Future-Proof Approach to Intelligent Buildings
3. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
4. Northrop Grumman Delivers Australian Automated Biometric Information System Trial Proof of Concept
5. Using graphene, scientists develop a less toxic way to rust-proof steel
6. ORNL microscopy yields first proof of ferroelectricity in simplest amino acid
7. Antidepressants for bipolar disorder
8. mTOR: A key brain signaling mechanism for rapidly acting antidepressants
9. OHSU Vollum Institute research gives new insight into how antidepressants work in the brain
10. Biochemical mapping helps explain who will respond to antidepressants
11. Do antidepressants impair the ability to extinguish fear?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... , February 3, 2016 ... new market research report "Automated Fingerprint Identification System Market ... Latent Search), Application (Banking & Finance, Government, Healthcare, and ... by MarketsandMarkets, the market is expected to be worth ... of 21.0% between 2015 and 2020. The transformation and ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... February 11, 2016 , ... ... cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, ... sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in the ...
(Date:2/11/2016)... --  BioInformant announces the February 2016 release of ... Tools, and Technologies – Market Size, Segments, Trends, and ... The first and only market research ... has more than a decade of historical information on ... cell type. This powerful 175 page global strategic report ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... its new stem cell treatment clinic in Quito, Ecuador. The new facility will ... trauma applications to patients from around the world. , The new GSCG ...
(Date:2/10/2016)...  The Maryland House of Delegates and House Speaker ... of Maryland School of Medicine Dean E. Albert ... Medical System President and CEO Robert Chrencik , ... honor given to the public by the leader of ... and Mr. Chrencik for their contributions to our ...
Breaking Biology Technology: